In race to develop coronavirus treatment, Regeneron sees an inside track

In race to develop coronavirus treatment, Regeneron sees an inside track

In the race to develop a coronavirus treatment, Regeneron thinks it has the inside track

By DAMIAN GARDE

ERICA YOON FOR STAT

Decades ago, the company set out to bend the curve of drug development by genetically engineering a mouse to have a fully human immune system.

READ MORE